New Delhi: In reply to a question in Rajya Sabha, Union Ayush Minister Shripad Naik said that the Council of Scientific and Industrial Research (CSIR) has developed the scientifically-validated hypoglycemic formulation is being sold as BGR-34 for type 2 diabetic patients. The herbal medicine is best suitable for those who are not dependent on insulin injections.

In response to a written query raised by Rajya Sabha member Jharna Das Baidya, the minister said, "The drug has been jointly developed by Lucknow-based CSIR's laboratories -- Central Institute of Medicinal & Aromatic Plants and National Botanical Research Institute."

"The know-how for the product was licensed to AIMIL Pharma which is manufacturing and marketing it as BGR-34," Naik said.

On the development, former senior NBRI scientist AKS Rawat, who has played a key role in developing the BGR-34, said that the minister's statement on the anti-diabetic herbal drug reflects the faith that the product has earned over the years among the patients suffering from type 2 diabetes.

Click here for News source

Information on this website is provided for informational purposes and is not meant to substitute for the advice provided by your own physician or other medical professionals. This website is meant for use by Indian residents only.